These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15477879)

  • 21. MMA supports Gov. Pawlenty's call for study of drug-marketing costs.
    Minn Med; 2006 Aug; 89(8):23. PubMed ID: 16967878
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 23. [Save us from idiocy].
    Bramness JG
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2083. PubMed ID: 8779151
    [No Abstract]   [Full Text] [Related]  

  • 24. Price controls boost innovation in Japan..
    Swinbanks D
    Nature; 1994 Apr; 368(6474):785. PubMed ID: 8159232
    [No Abstract]   [Full Text] [Related]  

  • 25. Prescription medications: effect on healthcare costs and dentistry.
    Capehart KL
    Dent Today; 2005 Apr; 24(4):12, 14. PubMed ID: 15884605
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 27. Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.
    Mathews AW
    Wall St J (East Ed); 2005 Aug; ():A1, A6. PubMed ID: 16222837
    [No Abstract]   [Full Text] [Related]  

  • 28. Albumin industry launches global promotion.
    Yamey G
    BMJ; 2000 Feb; 320(7234):533. PubMed ID: 10688548
    [No Abstract]   [Full Text] [Related]  

  • 29. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug samples are meant for advertising.
    Thawani V
    Issues Med Ethics; 2001; 9(3):91. PubMed ID: 16334483
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug industry is not to be subsidized by the society].
    Melander A
    Lakartidningen; 2004 Feb; 101(7):613; author reply 613. PubMed ID: 15024879
    [No Abstract]   [Full Text] [Related]  

  • 32. Who bears the costs of antidepressants in Australia?
    Burrows GD; Norman TR
    Med J Aust; 1995 Feb; 162(3):162; author reply 164. PubMed ID: 7854232
    [No Abstract]   [Full Text] [Related]  

  • 33. [New thinking necessary?].
    Lindberg M
    Ugeskr Laeger; 2003 Oct; 165(41):3939-40. PubMed ID: 14579559
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 35. Supported by an unrestricted educational grant.
    Chepesiuk R
    CMAJ; 2003 Sep; 169(5):421-2. PubMed ID: 12952803
    [No Abstract]   [Full Text] [Related]  

  • 36. Who bears the costs of antidepressants in Australia?
    Tiller JW
    Med J Aust; 1995 Feb; 162(3):163; author reply 164. PubMed ID: 7854235
    [No Abstract]   [Full Text] [Related]  

  • 37. A world of hurt.
    Simons J
    Fortune; 2005 Jan; 151(1):17-8, 20. PubMed ID: 15696651
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
    Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
    Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of antidepressant drug adherence on comorbid medication use and resource utilization.
    Katon W; Cantrell CR; Sokol MC; Chiao E; Gdovin JM
    Arch Intern Med; 2005 Nov; 165(21):2497-503. PubMed ID: 16314547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.